Earendil Labs
Earendil Labs develops protein therapeutics using AI models coupled with experimental antibody discovery and validation.
UndisclosedFinancing rounds disclosure
ParticipantS
Sanofi
Activity from announced rounds
Activity in this selectionOct 25, 2026 · Healthtech · Jan 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share